HIGHLIGHTS
- who: Aditi Sharma and colleagues from the Department of Pharmacology, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India have published the research work: Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer, in the Journal: Molecules 2023, 750 of /2023/
- what: The aim therapeutics is to a monoclonal antibody.
SUMMARY
Chemotherapy reduces the activity of oncogene BCR-ABL (Breakpoint cluster region-Abelson proto-oncogene) fusion and removes malignant cells and cancer-affected cells are destroyed by radiotherapy. Cancer can be treated with a variety of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.